mitoxantrone has been researched along with Body Weight in 12 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Age is a known susceptibility factor for the cardiotoxicity of several anticancer drugs, including mitoxantrone (MTX)." | 7.81 | The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury. ( Bastos, Mde L; Carvalho, F; Costa, VM; Dores-Sousa, JL; Duarte, JA; Seabra, V, 2015) |
| "In an attempt to improve the therapeutic effect of mitoxantrone (MTO) against breast cancer and its lymph node metastases, solid lipid nanoparticles (SLN) of MTO were prepared, characterized and evaluated on mice." | 7.73 | Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases. ( Chao, RB; Lu, B; Xiong, SB; Yang, H; Yin, XD, 2006) |
| "Age is a known susceptibility factor for the cardiotoxicity of several anticancer drugs, including mitoxantrone (MTX)." | 3.81 | The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury. ( Bastos, Mde L; Carvalho, F; Costa, VM; Dores-Sousa, JL; Duarte, JA; Seabra, V, 2015) |
| "In an attempt to improve the therapeutic effect of mitoxantrone (MTO) against breast cancer and its lymph node metastases, solid lipid nanoparticles (SLN) of MTO were prepared, characterized and evaluated on mice." | 3.73 | Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases. ( Chao, RB; Lu, B; Xiong, SB; Yang, H; Yin, XD, 2006) |
| " Angiogenesis was induced in normal adult rat mesentery by intraperitoneal injection of a low dosage of VEGF-A." | 1.38 | Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis. ( Albertsson, P; Lennernäs, B; Norrby, K, 2012) |
| "Mitoxantrone (MXN) has demonstrated therapeutic efficacy in the intraperitoneal treatment of malignancies." | 1.30 | Toxicity of a particulate formulation for the intraperitoneal application of mitoxantrone. ( Eichler, HG; Luftensteiner, CP; Paul, B; Schwendenwein, I; Viernstein, H; Wölfl, G, 1999) |
| "Ametantrone acetate is an antineoplastic drug chemically described as 1,4-bis [[2-[(2-hydroxyethyl)-amino] ethyl]amino] -9,10-anthracenedione diacetate salt." | 1.27 | Teratology studies of ametantrone acetate in rats and rabbits. ( Anderson, JA; de la Iglesia, FA; Fitzgerald, JE; Kim, SN; Petrere, JA; Schardein, JL, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brandão, SR | 1 |
| Reis-Mendes, A | 1 |
| Domingues, P | 1 |
| Duarte, JA | 2 |
| Bastos, ML | 1 |
| Carvalho, F | 2 |
| Ferreira, R | 1 |
| Costa, VM | 2 |
| Dores-Sousa, JL | 1 |
| Seabra, V | 1 |
| Bastos, Mde L | 1 |
| Niang, M | 1 |
| Soukup, T | 1 |
| Zivný, P | 1 |
| Tomšík, P | 1 |
| Bukač, J | 1 |
| Rezáčová, M | 1 |
| Stoklasová, A | 1 |
| Cerman, J | 1 |
| Sišpera, L | 1 |
| Albertsson, P | 1 |
| Lennernäs, B | 1 |
| Norrby, K | 1 |
| Almond, BA | 1 |
| Hadba, AR | 1 |
| Freeman, ST | 1 |
| Cuevas, BJ | 1 |
| York, AM | 1 |
| Detrisac, CJ | 1 |
| Goldberg, EP | 1 |
| Lu, B | 1 |
| Xiong, SB | 1 |
| Yang, H | 1 |
| Yin, XD | 1 |
| Chao, RB | 1 |
| Mullen, BM | 1 |
| Mattox, DE | 1 |
| Von Hoff, DD | 1 |
| Hearne, EM | 1 |
| Luftensteiner, CP | 1 |
| Schwendenwein, I | 1 |
| Eichler, HG | 1 |
| Paul, B | 1 |
| Wölfl, G | 1 |
| Viernstein, H | 1 |
| Los, G | 1 |
| Nagel, JD | 1 |
| McVie, JG | 1 |
| Mulder, PO | 1 |
| Bouman, JG | 1 |
| Gietema, JA | 1 |
| Van Rijsbergen, H | 1 |
| Mulder, NH | 1 |
| Van der Geest, S | 1 |
| De Vries, EG | 1 |
| Chandrasekaran, B | 1 |
| Dimling, J | 1 |
| Capizzi, RL | 1 |
| Petrere, JA | 1 |
| Kim, SN | 1 |
| Anderson, JA | 1 |
| Fitzgerald, JE | 1 |
| de la Iglesia, FA | 1 |
| Schardein, JL | 1 |
1 trial available for mitoxantrone and Body Weight
| Article | Year |
|---|---|
Hyperalimentation in autologous bone marrow transplantation for solid tumors. Comparison of total parenteral versus partial parenteral plus enteral nutrition.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marrow Transplantation; Com | 1989 |
11 other studies available for mitoxantrone and Body Weight
| Article | Year |
|---|---|
Exploring the aging effect of the anticancer drugs doxorubicin and mitoxantrone on cardiac mitochondrial proteome using a murine model.
Topics: Aging; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Body Weight; Citrate (si)-Syntha | 2021 |
The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury.
Topics: Age Factors; Animals; Antineoplastic Agents; Aspartate Aminotransferases; Biomarkers; Body Weight; C | 2015 |
Biochemical and pharmacological effects of mitoxantrone and acetyl-L-carnitine in mice with a solid form of Ehrlich tumour.
Topics: Acetylcarnitine; Animals; Antineoplastic Agents; Bilirubin; Body Weight; Carcinoma, Ehrlich Tumor; F | 2011 |
Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis.
Topics: Animals; Body Weight; Camptothecin; Endothelial Cells; Irinotecan; Male; Mesentery; Mitoxantrone; Ne | 2012 |
Efficacy of mitoxantrone-loaded albumin microspheres for intratumoral chemotherapy of breast cancer.
Topics: Adenocarcinoma; Albumins; Animals; Antineoplastic Agents; Body Weight; Female; Mammary Neoplasms, Ex | 2003 |
Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases.
Topics: Algorithms; Animals; Antineoplastic Agents; Body Weight; Breast Neoplasms; Cell Line, Tumor; Chlorof | 2006 |
The effect of preoperative adriamycin and dihydroxyanthracenedione on wound healing.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Body Weight; Doxorubicin; Female; Mitoxantrone; Preo | 1981 |
Toxicity of a particulate formulation for the intraperitoneal application of mitoxantrone.
Topics: Animals; Antineoplastic Agents; Blood Cell Count; Body Weight; Eating; Female; Humans; Injections, I | 1999 |
Anti-tumor effect of cisplatin, carboplatin, mitoxantrone, and doxorubicin on peritoneal tumor growth after intraperitoneal and intravenous chemotherapy: a comparative study.
Topics: Animals; Antineoplastic Agents; Body Weight; Carboplatin; Cisplatin; Doxorubicin; Injections, Intrap | 1990 |
Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line; Daunorubicin; Doxorubicin; Drug Resistance; | 1987 |
Teratology studies of ametantrone acetate in rats and rabbits.
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Dose-Response Relationship, Drug; Female; Gestati | 1986 |